{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:12:03Z","timestamp":1787505123548,"version":"build-2736575974"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1553"],"award-info":[{"award-number":["2023NSFSC1553"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0610"],"award-info":[{"award-number":["2024NSFSC0610"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0736"],"award-info":[{"award-number":["2024NSFSC0736"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115630","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:49:38Z","timestamp":1760543378000},"page":"115630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Glucose metabolism reprogramming in gastric cancer: Implications for tumor"],"prefix":"10.1016","volume":"167","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Rosalind","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wudian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10251","key":"10.1016\/j.intimp.2025.115630_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152341","article-title":"Epidemiology and prevention of gastric cancer: a comprehensive review","volume":"52","author":"Pradhan","year":"2025","journal-title":"Semin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0015","first-page":"468","article-title":"Epidemiological characteristics of gastric cancer in China and worldwide","volume":"47","author":"Yu","year":"2025","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030679","article-title":"Claudin 18.2 as a new biomarker in gastric cancer-what should we know?","volume":"16","author":"Mathias-Machado","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014430","article-title":"Clinical utility of miniprobe endoscopic ultrasonography for prediction of invasion depth of early gastric cancer: a meta-analysis of diagnostic test from PRISMA guideline","volume":"98","author":"Luo","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","article-title":"Molecular mechanism of helicobacter pylori-induced gastric cancer","volume":"52","author":"Alipour","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2025.115630_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126548","article-title":"Gastritis, gastric polyps and gastric cancer","volume":"22","author":"Waldum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2025.115630_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer","volume":"39","author":"Song","year":"2017","journal-title":"Tumour Biol."},{"issue":"38","key":"10.1016\/j.intimp.2025.115630_bb0050","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.3748\/wjg.v20.i38.13667","article-title":"Subtotal gastrectomy for gastric cancer","volume":"20","author":"Santoro","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6487","key":"10.1016\/j.intimp.2025.115630_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2025.115630_bb0060","first-page":"838","volume":"76","author":"Chen","year":"2019","journal-title":"R.J."},{"issue":"10","key":"10.1016\/j.intimp.2025.115630_bb0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5930","key":"10.1016\/j.intimp.2025.115630_bb0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115630_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063142","article-title":"Targeting the Warburg effect in cancer: where do we stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.intimp.2025.115630_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413666","article-title":"Glycolysis under circadian control","volume":"22","author":"Zlacka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115630_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101643","article-title":"Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment","volume":"36","author":"Endo","year":"2020","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg effect and the hallmarks of cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.intimp.2025.115630_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-030-51652-9_17","article-title":"HIF-1alpha metabolic pathways in human cancer","volume":"1280","author":"Elzakra","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0115","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/15548627.2015.1042195","article-title":"HK2\/hexokinase-II integrates glycolysis and autophagy to confer cellular protection","volume":"11","author":"Tan","year":"2015","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29010075","article-title":"The promoting role of HK II in tumor development and the research progress of its inhibitors","volume":"29","author":"Liu","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0125","first-page":"9264","article-title":"Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer","volume":"8","author":"Gao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.intimp.2025.115630_bb0130","article-title":"G6PD-NF-kappaB-HGF signal in gastric cancer-associated mesenchymal stem cells promotes the proliferation and metastasis of gastric cancer cells by upregulating the expression of HK2","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115630_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jprot.2018.07.013","article-title":"Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer","volume":"186","author":"Fernandez-Coto","year":"2018","journal-title":"J. Proteome"},{"key":"10.1016\/j.intimp.2025.115630_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111075","article-title":"N(6)-methyladenosine (m(6)a) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability","volume":"133","author":"Yu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0145","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5546","article-title":"circRPS19 affects HK2-mediated aerobic glycolysis and cell viability via the miR-125a-5p\/USP7 pathway in gastric cancer","volume":"63","author":"Zheng","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2025.115630_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.omtn.2020.08.023","article-title":"Circular RNA circCUL3 accelerates the Warburg effect progression of gastric cancer through regulating the STAT3\/HK2 Axis","volume":"22","author":"Pu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/CBM-160619","article-title":"MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene","volume":"17","author":"Li","year":"2016","journal-title":"Cancer Biomark."},{"issue":"10","key":"10.1016\/j.intimp.2025.115630_bb0160","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1111\/jcmm.14523","article-title":"Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA\/EGFR\/HK II axis","volume":"23","author":"Yu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115630_bb0165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12935-020-01275-y","article-title":"SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis","volume":"20","author":"Shao","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10120-022-01340-7","article-title":"Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK\/JUN\/HK2 axis regulated glycolysis","volume":"26","author":"Mi","year":"2023","journal-title":"Gastric Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0175","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/0008-5472.CAN-21-1820","article-title":"Disrupting circadian rhythm via the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0180","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/1120009X.2022.2157618","article-title":"LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis","volume":"35","author":"Xu","year":"2023","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12894-024-01444-5","article-title":"The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Urol."},{"key":"10.1016\/j.intimp.2025.115630_bb0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2025.115630_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.143956","article-title":"Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells","volume":"712","author":"Li","year":"2019","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/auto.27345","article-title":"The glycolytic enzyme PFKFB3\/phosphofructokinase regulates autophagy","volume":"10","author":"Yang","year":"2014","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yexcr.2019.04.022","article-title":"Protein kinase D3 promotes gastric cancer development through p65\/6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 activation of glycolysis","volume":"380","author":"Zhang","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.intimp.2025.115630_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163768","article-title":"PFK15, a small molecule inhibitor of PFKFB3, induces cell cycle arrest, apoptosis and inhibits invasion in gastric cancer","volume":"11","author":"Zhu","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0215","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/1878-0261.12689","article-title":"Histone methyltransferase SETD1A interacts with HIF1alpha to enhance glycolysis and promote cancer progression in gastric cancer","volume":"14","author":"Wu","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2025.115630_bb0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2020.00159","article-title":"Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis","volume":"10","author":"Zahra","year":"2020","journal-title":"Front. Oncol."},{"issue":"2 Pt A","key":"10.1016\/j.intimp.2025.115630_bb0225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0230","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12964-023-01112-5","article-title":"Neutrophil extracellular traps induced by the hypoxic microenvironment in gastric cancer augment tumour growth","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0235","first-page":"3","article-title":"Targeting HIF-1alpha signaling pathway for gastric cancer treatment","volume":"74","author":"Li","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.intimp.2025.115630_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0245","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-017-03031-1","article-title":"PKM2 promotes cell migration and inhibits autophagy by mediating PI3K\/AKT activation and contributes to the malignant development of gastric cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.intimp.2025.115630_bb0250","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.3748\/wjg.v18.i30.4037","article-title":"Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer","volume":"18","author":"Lim","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2012.05.063","article-title":"Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level","volume":"423","author":"Kwon","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2025.115630_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1088","article-title":"Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer","volume":"12","author":"Dai","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0265","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.18632\/aging.203643","article-title":"MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2","volume":"14","author":"Liu","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290688","article-title":"USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2","volume":"18","author":"Chen","year":"2023","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0275","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1186\/s12967-023-04658-7","article-title":"Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115630_bb0280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2147\/CMAR.S292306","article-title":"PolG inhibits gastric cancer glycolysis and viability by suppressing PKM2 phosphorylation","volume":"13","author":"Lv","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0285","doi-asserted-by":"crossref","first-page":"790","DOI":"10.21037\/tcr-20-2597","article-title":"Rab25 acts as an oncogene and participates in the regulation of aerobic glycolysis via PKM2 in gastric adenocarcinoma","volume":"10","author":"Zheng","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115630_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.767116","article-title":"PKM2 is the target of a multi-herb-combined decoction during the inhibition of gastric cancer progression","volume":"11","author":"Sun","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115630_bb0295","article-title":"circATP2B1 promotes aerobic glycolysis in gastric cancer cells through regulation of the miR-326 gene cluster","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ijo.2012.1687","article-title":"Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target","volume":"42","author":"Hur","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0305","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7150\/jca.34330","article-title":"Pyruvate dehydrogenase kinase 1 interferes with glucose metabolism reprogramming and mitochondrial quality control to aggravate stress damage in cancer","volume":"11","author":"Deng","year":"2020","journal-title":"J. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2025.115630_bb0310","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2025.115630_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5801209","article-title":"Reactive oxygen species-mediated tumor microenvironment transformation: the mechanism of radioresistant gastric cancer","volume":"2018","author":"Gu","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0320","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1631\/jzus.B2200351","article-title":"AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer","volume":"24","author":"Li","year":"2023","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"10.1016\/j.intimp.2025.115630_bb0325","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20209330","article-title":"MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin","volume":"53","author":"Qian","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.intimp.2025.115630_bb0330","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/OTT.S189687","article-title":"Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111846","article-title":"Lactic acid promotes macrophage polarization through MCT-HIF1alpha signaling in gastric cancer","volume":"388","author":"Zhang","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"21","key":"10.1016\/j.intimp.2025.115630_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115630_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114180","article-title":"Targeting regulatory T cells in gastric cancer: pathogenesis, immunotherapy, and prognosis","volume":"158","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115630_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102076","article-title":"The cross-talk between tumor cells and activated fibroblasts mediated by lactate\/BDNF\/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer","volume":"46","author":"Jin","year":"2021","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.07.004","article-title":"Microbial carcinogenesis: lactic acid bacteria in gastric cancer","volume":"1872","author":"Vinasco","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0360","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11845-013-0909-y","article-title":"Lactic acid bacterial extracts as anti-helicobacter pylori: a molecular approach","volume":"182","author":"El-Adawi","year":"2013","journal-title":"Ir. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0365","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"TeSlaa","year":"2023","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0370","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3892\/or.2020.7803","article-title":"Exploring the role of glucose-6-phosphate dehydrogenase in cancer (review)","volume":"44","author":"Li","year":"2020","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0375","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/onc.2016.187","article-title":"REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13277-011-0251-9","article-title":"Overexpression of G6PD is associated with poor clinical outcome in gastric cancer","volume":"33","author":"Wang","year":"2012","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0385","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41392-020-00326-0","article-title":"NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications","volume":"5","author":"Ju","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115630_bb0390","article-title":"6-Phosphogluconolactonase promotes hepatocellular carcinogenesis by activating pentose phosphate pathway","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2025.115630_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9369358","article-title":"Expression of pentose phosphate pathway-related proteins in breast cancer","volume":"2018","author":"Choi","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.intimp.2025.115630_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.589570","article-title":"Imaging 6-phosphogluconolactonase activity in brain tumors in vivo using hyperpolarized delta-[1-(13)C]gluconolactone","volume":"11","author":"Batsios","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24189","article-title":"Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer","volume":"36","author":"Yuan","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0410","article-title":"6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress","volume":"18","author":"Chen","year":"2023","journal-title":"Open Life Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0415","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.intimp.2025.115630_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113607","article-title":"The role of transketolase in human cancer progression and therapy","volume":"154","author":"Hao","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.intimp.2025.115630_bb0425","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/cbt.9.9.11431","article-title":"Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo","volume":"9","author":"Yuan","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0430","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12935-023-03077-4","article-title":"FOXA1\/MND1\/TKT axis regulates gastric cancer progression and oxaliplatin sensitivity via PI3K\/AKT signaling pathway","volume":"23","author":"Hu","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0435","doi-asserted-by":"crossref","first-page":"743","DOI":"10.21037\/tcr-22-2292","article-title":"Ferula sinkiangensis against gastric cancer: a network pharmacology, molecular docking and cell experiment study","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0440","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3748\/wjg.v18.i11.1216","article-title":"Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers","volume":"18","author":"Kocevar","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.115630_bb0445","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2017.07.018","article-title":"Control of the NADPH supply for oxidative stress handling in cancer cells","volume":"112","author":"Moreno-Sanchez","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2025.115630_bb0450","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2018.05.014","article-title":"Glutathione system in animal model of solid tumors: from regulation to therapeutic target","volume":"128","author":"Corso","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115630_bb0455","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","article-title":"Oxidative stress and its role in cancer","volume":"17","author":"Jelic","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.intimp.2025.115630_bb0465","article-title":"Myoferlin disturbs redox equilibrium to accelerate gastric cancer migration","volume":"12","author":"Shi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115630_bb0470","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.2147\/OTT.S208848","article-title":"OGDH promotes the progression of gastric cancer by regulating mitochondrial bioenergetics and Wnt\/beta-catenin signal pathway","volume":"12","author":"Lu","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0475","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4149\/neo_2022_220714N714","article-title":"PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance","volume":"69","author":"Zhang","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.intimp.2025.115630_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108664","article-title":"Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer","volume":"696","author":"Wang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0485","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12943-025-02302-0","article-title":"Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK\/mTOR pathway","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0490","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1007\/s11033-023-08535-w","article-title":"The role of GLUT2 in glucose metabolism in multiple organs and tissues","volume":"50","author":"Sun","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2025.115630_bb0495","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Asp. Med."},{"issue":"15","key":"10.1016\/j.intimp.2025.115630_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158698","article-title":"Importance of GLUT transporters in disease diagnosis and treatment","volume":"23","author":"Ismail","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0505","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/CAD.0b013e328334562c","article-title":"Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells","volume":"21","author":"Won","year":"2010","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0510","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3346\/jkms.2000.15.4.420","article-title":"Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma","volume":"15","author":"Kim","year":"2000","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.intimp.2025.115630_bb0515","doi-asserted-by":"crossref","DOI":"10.12659\/MSMBR.920778","article-title":"Glucose Transporter-1 (GLUT-1) expression is associated with tumor size and poor prognosis in locally advanced gastric cancer","volume":"26","author":"Yin","year":"2020","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0520","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X","article-title":"Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival","volume":"92","author":"Kawamura","year":"2001","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0525","first-page":"2044","article-title":"Potential role of glucose Transporter-1 expression in gastric cancer: a meta-analysis and systematic review","volume":"49","author":"Tao","year":"2020","journal-title":"Iran. J. Public Health"},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0530","first-page":"2423","article-title":"Inhibition of glucose-transporter 1 (GLUT-1) expression reversed Warburg effect in gastric cancer cell MKN45","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10120-015-0577-x","article-title":"Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival","volume":"20","author":"Schlosser","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.intimp.2025.115630_bb0540","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12935-020-01599-9","article-title":"SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer","volume":"20","author":"Yao","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"18","key":"10.1016\/j.intimp.2025.115630_bb0545","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.ejca.2005.09.008","article-title":"Is the hypoxia-inducible factor pathway important in gastric cancer?","volume":"41","author":"Griffiths","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0550","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000374060","article-title":"p38MAPK signaling enhances glycolysis through the up-regulation of the glucose transporter GLUT-4 in gastric cancer cells","volume":"36","author":"Liu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0555","first-page":"27","article-title":"Recombinant methioninase regulates PI3K\/Akt\/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells","volume":"40","author":"Zhou","year":"2020","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0560","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbcan.2019.05.006","article-title":"Gluconeogenesis in cancer cells - repurposing of a starvation-induced metabolic pathway?","volume":"1872","author":"Grasmann","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0565","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40170-021-00256-7","article-title":"Pyruvate carboxylase and cancer progression","volume":"9","author":"Kiesel","year":"2021","journal-title":"Cancer Metab."},{"issue":"9","key":"10.1016\/j.intimp.2025.115630_bb0570","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1111\/cas.15453","article-title":"Long noncoding RNA OVAAL enhances nucleotide synthesis through pyruvate carboxylase to promote 5-fluorouracil resistance in gastric cancer","volume":"113","author":"Tan","year":"2022","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0575","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00432-021-03820-2","article-title":"Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10-pyruvate carboxylase axis","volume":"148","author":"Wang","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.115630_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101257","article-title":"Phosphoenolpyruvate carboxykinase in cell metabolism: roles and mechanisms beyond gluconeogenesis","volume":"53","author":"Yu","year":"2021","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0585","doi-asserted-by":"crossref","first-page":"17841","DOI":"10.1038\/s41598-017-18064-9","article-title":"Transcriptomic analysis of mitochondrial TFAM depletion changing cell morphology and proliferation","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2025.115630_bb0590","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neo.2018.03.008","article-title":"SIRT2 promotes the migration and invasion of gastric cancer through RAS\/ERK\/JNK\/MMP-9 pathway by increasing PEPCK1-related metabolism","volume":"20","author":"Li","year":"2018","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0595","article-title":"Activated integrated stress response induced by Salubrinal promotes cisplatin resistance in human gastric cancer cells via enhanced xCT expression and glutathione biosynthesis","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0600","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5114\/ceji.2021.111753","article-title":"Gastric cancer mesenchymal stem cells inhibit natural killer cell function by up-regulating FBP1","volume":"46","author":"Han","year":"2021","journal-title":"Cent. Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115630_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167857","article-title":"Downregulation of FBP1 promotes tumor metastasis and indicates poor prognosis in gastric cancer via regulating epithelial-mesenchymal transition","volume":"11","author":"Li","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0610","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000480314","article-title":"Snail enhances glycolysis in the epithelial-mesenchymal transition process by targeting FBP1 in gastric cancer","volume":"43","author":"Yu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0615","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1476-4598-12-110","article-title":"Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0620","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbrc.2018.03.083","article-title":"Hepatic glucose-6-phosphatase-alpha deficiency leads to metabolic reprogramming in glycogen storage disease type Ia","volume":"498","author":"Cho","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.intimp.2025.115630_bb0625","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0630","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/mc.23681","article-title":"The FOXO1\/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K\/AKT\/mTOR signaling pathway","volume":"63","author":"Han","year":"2024","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0635","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","article-title":"Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0640","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.intimp.2025.115630_bb0645","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0650","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0655","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.7314\/APJCP.2013.14.8.4685","article-title":"Autophagy inhibition sensitizes cisplatin cytotoxicity in human gastric cancer cell line SGC7901","volume":"14","author":"Zhang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0660","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020404","article-title":"Targeting cancer metabolism to resensitize chemotherapy: potential development of cancer chemosensitizers from traditional Chinese medicines","volume":"12","author":"Guo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0670","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jare.2017.06.006","article-title":"Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies - a review","volume":"8","author":"Al-Abd","year":"2017","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0675","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12885-025-14141-9","article-title":"GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells","volume":"25","author":"Hayashi","year":"2025","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113332","article-title":"The potential of lonidamine in combination with chemotherapy and physical therapy in cancer treatment","volume":"12","author":"Huang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2025.115630_bb0685","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106214","article-title":"Characterization of glycometabolism and tumor immune microenvironment for predicting clinical outcomes in gastric cancer","volume":"26","author":"Shi","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0695","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12906-022-03669-z","article-title":"Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions","volume":"22","author":"Lv","year":"2022","journal-title":"BMC Complement. Med. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.115630_bb0700","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.132","article-title":"Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans","volume":"4","author":"Yang","year":"2013","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.intimp.2025.115630_bb0705","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41389-019-0168-5","article-title":"Rev-erbalpha inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells","volume":"8","author":"Tao","year":"2019","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0710","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","article-title":"A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial(\u2606)","volume":"32","author":"Park","year":"2021","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0715","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s10120-020-01136-7","article-title":"Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial","volume":"24","author":"Iwasaki","year":"2021","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2025.115630_bb0720","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0725","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0730","first-page":"481","article-title":"Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian clinical research oncology group (GOIRC)","volume":"70","author":"De Lisi","year":"1986","journal-title":"Cancer Treat. Rep."},{"issue":"9742","key":"10.1016\/j.intimp.2025.115630_bb0735","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.intimp.2025.115630_bb0740","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase III trial of Apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction","volume":"34","author":"Li","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.intimp.2025.115630_bb0745","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1200\/JCO.24.01119","article-title":"Randomized phase III trial of ramucirumab beyond progression plus irinotecan in patients with ramucirumab-refractory advanced gastric cancer: RINDBeRG trial","volume":"43","author":"Sakai","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0750","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol."},{"issue":"10294","key":"10.1016\/j.intimp.2025.115630_bb0755","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0760","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CAD.0000000000000684","article-title":"Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells","volume":"30","author":"He","year":"2019","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"10.1016\/j.intimp.2025.115630_bb0765","first-page":"1181","article-title":"Licochalcone a suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway","volume":"39","author":"Wu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2025.115630_bb0770","first-page":"1","article-title":"Anthocyanins and proanthocyanidins synergistically inhibit the growth of gastric cancer cells in vitro: exploring the potential physiological activity of grape and red wine","author":"Wang","year":"2024","journal-title":"Nat. Prod. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115630_bb0775","first-page":"226","article-title":"WD-3 inhibits the proliferation of breast cancer cells by regulating the glycolytic pathway","volume":"20","author":"Zhu","year":"2020","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115630_bb0780","first-page":"1423","article-title":"Metformin inhibits gastric cancer via the inhibition of HIF1alpha\/PKM2 signaling","volume":"5","author":"Chen","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.115630_bb0785","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1248\/bpb.b21-00443","article-title":"Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1\/PKM2\/GLUT1 expression","volume":"44","author":"Dai","year":"2021","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.intimp.2025.115630_bb0790","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s12033-023-00778-z","article-title":"KAT2A promotes the Succinylation of PKM2 to inhibit its activity and accelerate glycolysis of gastric cancer","volume":"66","author":"Zhang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115630_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113665","article-title":"Celastrus orbiculatus Thunb. extract inhibits inflammatory metabolic adaptation in macrophages and regulates polarization via modulating PKM2","volume":"144","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115630_bb0800","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3892\/ol.2015.3912","article-title":"Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2","volume":"11","author":"Shen","year":"2016","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.intimp.2025.115630_bb0805","first-page":"520","article-title":"Effects of astragalin on apoptosis of undifferentiated gastric cancer cells","volume":"38","author":"Chu","year":"2022","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"10.1016\/j.intimp.2025.115630_bb0810","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6981520","article-title":"beta-Asarone increases chemosensitivity by inhibiting tumor glycolysis in gastric cancer","volume":"2020","author":"Tao","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:34:30Z","timestamp":1765456470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925016212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":162,"alternative-id":["S1567576925016212"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115630","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose metabolism reprogramming in gastric cancer: Implications for tumor","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115630"}}